Monoclonal Antibodies Market Sales are Anticipated to reach US$ 588.0 Billion by 2032, Increasing at 11.8% CAGR: Market.us Report
May 26, 2023 01:50 ET
|
Market.Us
New York, May 26, 2023 (GLOBE NEWSWIRE) -- The Monoclonal Antibodies Market size was valued at USD 198.2 Bn in 2022. The total market revenue is expected to grow at a CAGR of 11.8%, reaching...
Protein Engineering Market Predicted to Garner USD 9,329 Million | CAGR of 13.6%
May 23, 2023 08:43 ET
|
Market.Us
New York, May 23, 2023 (GLOBE NEWSWIRE) -- The Protein Engineering Market size is projected to surpass around USD 9,329 Million by 2032, and it is poised to reach a CAGR of 13.6% from 2023 to 2032....
CAGR of 5.6%, Red Biotechnology Market Expected to Surpass USD 609.6 Billion by 2031 – Exclusive Study by TMR
May 12, 2023 08:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 12, 2023 (GLOBE NEWSWIRE) -- The global red biotechnology market size stood at USD 357.2 Bn in 2021 and is anticipated to surpass value of USD 609.6 Bn by...
Avid Bioservices to Participate in RBC Capital Markets Global Healthcare Conference
May 10, 2023 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Dyadic Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
May 10, 2023 16:00 ET
|
Dyadic International, Inc.
New research collaboration with a Top 5 pharmaceutical company to develop C1 expressed vaccine antigen for human healthExpanded licensing agreement with Rubic One Health (“Rubic”) to develop,...
Dyadic to Participate at Two Industry Events in May
May 10, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., May 10, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Dyadic to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023
April 26, 2023 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., April 26, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Biologics Market Worth USD 718.97 Billion to 2031 with 7.50% CAGR | Reveals Latest InsightAce Study
April 17, 2023 10:37 ET
|
InsightAce Analytic Pvt. LTd.
Jersey City, NJ, April 17, 2023 (GLOBE NEWSWIRE) -- The Global Biologics Market is estimated to reach over USD 718.97 billion by 2031, exhibiting a CAGR of 7.50% during the forecast period. A...
Avid Bioservices Unveils Completed Mammalian Cell Facilities Expansion Providing Significantly Increased Capacity for Existing and Future Customers
April 04, 2023 08:05 ET
|
Avid Bioservices, Inc
Company to Host Open House to Celebrate Official Launch of Newest CGMP Mammalian Cell Manufacturing Suites within Myford Facility First Customer Project in Newly Expanded Capacity to Kick-Off This...
Global Bioprocess Validation Market is anticipated to cross US$ 449.03 Million by 2033 end at an aggressive CAGR of 9.20% | Deep analysis by Future Market Insights, Inc.
March 31, 2023 09:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, March 31, 2023 (GLOBE NEWSWIRE) -- As per the current market research conducted by FMI, the global Bioprocess Validation Market is expected to record a CAGR of 9.20% from 2023 to 2033....